WBC
BSX icon

Westpac Banking Corp’s Boston Scientific BSX Stock Holding History

Westpac Banking Corp’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$900K Sell
14,346
-1,180
-8% -$94.4K 0.06% 212
2025
Q4 		$1.48M Buy
15,526
+2,742
+21% +$269K 0.09% 184
2025
Q3 		$1.25M Sell
12,784
-379
-3% -$39.2K 0.08% 196
2025
Q2 		$1.41M Buy
13,163
+345
+3% +$34.9K 0.09% 177
2025
Q1 		$1.29M Sell
12,818
-3,092
-19% -$311K 0.1% 201
2024
Q4 		$1.42M Sell
15,910
-845
-5% -$74.4K 0.09% 193
2024
Q3 		$1.4M Buy
16,755
+3,281
+24% +$259K 0.09% 197
2024
Q2 		$1.04M Hold
13,474
– – 0.08% 194
2024
Q1 		$923K Buy
13,474
+85
+0.6% +$5.46K 0.07% 212
2023
Q4 		$774K Buy
13,389
+703
+6% +$37.5K 0.06% 217
2023
Q3 		$670K Sell
12,686
-109,842
-90% -$5.76M 0.05% 277
2023
Q2 		$6.63M Sell
122,528
-128,026
-51% -$6.69M 0.47% 46
2023
Q1 		$12.5M Sell
250,554
-174,840
-41% -$8.24M 0.17% 162
2022
Q4 		$19.7M Sell
425,394
-10,379
-2% -$449K 0.29% 86
2022
Q3 		$16.9M Sell
435,773
-11,454
-3% -$459K 0.26% 100
2022
Q2 		$16.7M Sell
447,227
-4,573
-1% -$186K 0.22% 122
2022
Q1 		$20M Sell
451,800
-3,961
-0.9% -$172K 0.23% 110
2021
Q4 		$19.4M Sell
455,761
-106,729
-19% -$4.48M 0.2% 126
2021
Q3 		$24.4M Sell
562,490
-501
-0.1% -$22.2K 0.26% 86
2021
Q2 		$24.1M Buy
562,991
+35,294
+7% +$1.48M 0.24% 97
2021
Q1 		$20.4M Buy
527,697
+409,615
+347% +$15.5M 0.23% 116
2020
Q4 		$4.25M Hold
118,082
– – 0.05% 438
2020
Q3 		$4.51M Buy
118,082
+13,838
+13% +$533K 0.06% 374
2020
Q2 		$3.66M Sell
104,244
-14,987
-13% -$540K 0.05% 411
2020
Q1 		$3.89M Hold
119,231
– – 0.07% 333
2019
Q4 		$5.39M Sell
119,231
-76,737
-39% -$3.21M 0.07% 369
2019
Q3 		$7.97M Sell
195,968
-21,729
-10% -$921K 0.11% 261
2019
Q2 		$9.36M Buy
217,697
+116,417
+115% +$4.48M 0.14% 194
2019
Q1 		$3.89M Sell
101,280
-67,686
-40% -$2.59M 0.06% 344
2018
Q4 		$5.97M Sell
168,966
-49
-0% -$1.78K 0.1% 279
2018
Q3 		$6.51M Buy
169,015
+67,735
+67% +$2.37M 0.11% 260
2018
Q2 		$3.31M Hold
101,280
– – 0.06% 335
2018
Q1 		$2.77M Buy
101,280
+19,792
+24% +$538K 0.06% 353
2017
Q4 		$2.02M Sell
81,488
-17,333
-18% -$478K 0.05% 359
2017
Q3 		$2.88M Sell
98,821
-2,021
-2% -$55.8K 0.06% 354
2017
Q2 		$2.8M Hold
100,842
– – 0.06% 359
2017
Q1 		$2.51M Buy
100,842
+18,921
+23% +$460K 0.02% 526
2016
Q4 		$1.94M Hold
81,921
– – 0.02% 485
2016
Q3 		$1.95M Buy
81,921
+8,053
+11% +$192K 0.02% 469
2016
Q2 		$1.73M Buy
73,868
+17,458
+31% +$378K 0.02% 523
2016
Q1 		$1.06M Buy
56,410
+574
+1% +$10.1K 0.01% 536
2015
Q4 		$1.03M Sell
55,836
-250
-0.4% -$4.48K 0.01% 568
2015
Q3 		$920K Buy
56,086
+47,716
+570% +$816K 0.01% 534
2015
Q2 		$148K Sell
8,370
-71,862
-90% -$1.28M ﹤0.01% 687
2015
Q1 		$1.59M Sell
80,232
-5,074
-6% -$80.2K 0.01% 534
2014
Q4 		$1.13M Sell
85,306
-5,969
-7% -$76.3K 0.01% 591
2014
Q3 		$1.08M Sell
91,275
-1,460,800
-94% -$18.4M 0.01% 601
2014
Q2 		$19.8M Buy
1,552,075
+5,753
+0.4% +$74.8K 0.19% 129
2014
Q1 		$20.9M Buy
1,546,322
+147,738
+11% +$1.94M 0.22% 109
2013
Q4 		$16.8M Sell
1,398,584
-358,500
-20% -$4.24M 0.19% 138
2013
Q3 		$20.6M Sell
1,757,084
-192,720
-10% -$2.08M 0.26% 95
2013
Q2 		$17.3M Buy
+1,949,804
New +$16.5M 0.26% 100

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Westpac Banking Corp's BSX Position: Q1 2026 in Review

Westpac Banking Corp reduced its Boston Scientific (BSX) stake by 7.6% in Q1 2026, selling an estimated $94.4K and leaving 14,346 shares worth $900K. The position accounts for 0.06% of the portfolio, ranked #212.

Westpac Banking Corp first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.4M in Q3 2021. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Westpac Banking Corp held 14,346 shares of Boston Scientific worth $900K as of Q1 2026.
  • Westpac Banking Corp sold 1,180 Boston Scientific shares in Q1 2026, an estimated $94.4K.
  • Boston Scientific made up 0.06% of Westpac Banking Corp's portfolio in Q1 2026, its #212 holding.
  • Westpac Banking Corp first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
  • Westpac Banking Corp's Boston Scientific position peaked at $24.4M in Q3 2021.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.